Log in

NASDAQ:FLDM - Fluidigm Stock Price, Forecast & News

$3.65
+0.01 (+0.27 %)
(As of 02/16/2020 04:00 PM ET)
Add
Today's Range
$3.45
Now: $3.65
$3.68
50-Day Range
$3.31
MA: $3.75
$4.35
52-Week Range
$2.12
Now: $3.65
$14.90
Volume291,957 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Fluidigm Corporation creates, manufactures, and markets technologies and tools for life sciences research in the United States and Europe. It offers analytical systems comprising Helios, a CyTOF system, Hyperion imaging system, and Hyperion tissue imager; and assays and reagents, including Maxpar reagents and Maxpar human immune monitoring panel kit and workflow. Read More…

Industry, Sector and Symbol

Industry N/A
Sub-IndustryLife Sciences Tools & Services
SectorN/A
Current SymbolNASDAQ:FLDM
CUSIP34385P10
WebN/A
PhoneN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees535
Next Earnings Date5/7/2020 (Estimated)
OptionableOptionable

Receive FLDM News and Ratings via Email

Sign-up to receive the latest news and ratings for FLDM and its competitors with MarketBeat's FREE daily newsletter.


Fluidigm (NASDAQ:FLDM) Frequently Asked Questions

What is Fluidigm's stock symbol?

Fluidigm trades on the NASDAQ under the ticker symbol "FLDM."

How were Fluidigm's earnings last quarter?

Fluidigm Co. (NASDAQ:FLDM) announced its quarterly earnings data on Monday, February, 10th. The medical research company reported ($0.18) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.13) by $0.05. The medical research company earned $32.44 million during the quarter, compared to the consensus estimate of $32.14 million. Fluidigm's revenue was up .4% on a year-over-year basis. View Fluidigm's Earnings History.

When is Fluidigm's next earnings date?

Fluidigm is scheduled to release their next quarterly earnings announcement on Thursday, May 7th 2020. View Earnings Estimates for Fluidigm.

What guidance has Fluidigm issued on next quarter's earnings?

Fluidigm issued an update on its FY 2020 After-Hours earnings guidance on Monday, February, 10th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $126.622-130.14 million, compared to the consensus revenue estimate of $124.85 million.

What price target have analysts set for FLDM?

4 brokers have issued 12 month price objectives for Fluidigm's shares. Their forecasts range from $7.00 to $16.00. On average, they expect Fluidigm's stock price to reach $11.75 in the next year. This suggests a possible upside of 221.9% from the stock's current price. View Analyst Price Targets for Fluidigm.

What is the consensus analysts' recommendation for Fluidigm?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Fluidigm in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Fluidigm.

Has Fluidigm been receiving favorable news coverage?

Media headlines about FLDM stock have trended somewhat positive recently, InfoTrie Sentiment Analysis reports. InfoTrie ranks the sentiment of press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Fluidigm earned a media sentiment score of 0.8 on InfoTrie's scale. They also gave headlines about the medical research company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the next few days. View News Stories for Fluidigm.

Are investors shorting Fluidigm?

Fluidigm saw a increase in short interest in January. As of January 31st, there was short interest totalling 2,060,000 shares, an increase of 18.4% from the January 15th total of 1,740,000 shares. Based on an average daily volume of 1,020,000 shares, the short-interest ratio is presently 2.0 days. Currently, 3.0% of the company's stock are sold short. View Fluidigm's Current Options Chain.

Who are some of Fluidigm's key competitors?

What other stocks do shareholders of Fluidigm own?

Who are Fluidigm's key executives?

Fluidigm's management team includes the folowing people:
  • Mr. Stephen Christopher Linthwaite, Pres, CEO & Director (Age 46)
  • Mr. Vikram Jog, CFO & Principal Accounting Officer (Age 63)
  • Mr. Nicholas S. Khadder, Sr. VP, Gen. Counsel & Corp. Sec. (Age 45)
  • Ms. Mai Chan Yow, MD of Fluidigm Singapore Pte Ltd & EVP of Worldwide Manufacturing - Fluidigm Singapore Pte Ltd (Age 60)
  • Dr. Stephen R. Quake, Co-Founder & Chairman of Advisory Board

Who are Fluidigm's major shareholders?

Fluidigm's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Russell Investments Group Ltd. (8.42%), Levin Easterly Partners LLC (6.30%), Partner Fund Management L.P. (4.65%), Renaissance Technologies LLC (4.01%), Acadian Asset Management LLC (2.43%) and State Street Corp (2.03%). Company insiders that own Fluidigm stock include Levin Capital Strategies, LP, Levin Easterly Partners Llc, Nicolas Barthelemy, Samuel D Colella and Stephen Christopher Linthwaite. View Institutional Ownership Trends for Fluidigm.

Which major investors are selling Fluidigm stock?

FLDM stock was sold by a variety of institutional investors in the last quarter, including Levin Easterly Partners LLC, Schonfeld Strategic Advisors LLC, Goldman Sachs Group Inc., Cubist Systematic Strategies LLC, AQR Capital Management LLC, Cadence Capital Management LLC, New York State Common Retirement Fund and Bank of America Corp DE. Company insiders that have sold Fluidigm company stock in the last year include Levin Easterly Partners Llc and Nicolas Barthelemy. View Insider Buying and Selling for Fluidigm.

Which major investors are buying Fluidigm stock?

FLDM stock was acquired by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Alyeska Investment Group L.P., Jacobs Levy Equity Management Inc., Acadian Asset Management LLC, Parkman Healthcare Partners LLC, Silverback Asset Management LLC, Dupont Capital Management Corp and Partner Fund Management L.P.. Company insiders that have bought Fluidigm stock in the last two years include Levin Capital Strategies, LP, Samuel D Colella and Stephen Christopher Linthwaite. View Insider Buying and Selling for Fluidigm.

How do I buy shares of Fluidigm?

Shares of FLDM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Fluidigm's stock price today?

One share of FLDM stock can currently be purchased for approximately $3.65.


MarketBeat Community Rating for Fluidigm (NASDAQ FLDM)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  493 (Vote Outperform)
Underperform Votes:  313 (Vote Underperform)
Total Votes:  806
MarketBeat's community ratings are surveys of what our community members think about Fluidigm and other stocks. Vote "Outperform" if you believe FLDM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FLDM will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/16/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel